The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors

Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors

— FDA Approvals, Deep Mineral Finds, AI-Powered Drug Leads, Global Health Vaccine and Wireless Signals, Solutions Capture Market Attention —

Tenon Medical (NASDAQ: TNON) earned FDA clearance for expanded use of its Catamaran® SI Joint Fusion System, now approved to support thoracolumbar spinal fusion—unlocking a larger surgical market opportunity.

Power Metallic Mines (TSXV: PNPN | OTCBB: PNPNF) announced its deepest assay yet from the Lion Zone and initial Ni/Cu results from the Tiger Zone. Borehole EM continues to pinpoint high-potential sulphide targets for expanded exploration.

Predictive Oncology (NASDAQ: POAI) leveraged AI and live-cell tumor data to model responses from 21 novel natural compounds. Several outperformed standard chemo drugs, pushing forward next-gen cancer drug discoveries.

Dyadic International (NASDAQ: DYAI) is accelerating global vaccine innovation with its C1 biomanufacturing platform, now funded by the Gates Foundation and CEPI. Designed to cut production time and costs, C1 enables rapid, affordable development of non-mRNA vaccines—including potential Bird Flu solutions. See Entire Article, read now!

Peraso Inc. (NASDAQ: PRSO) secured a $3.6 million order from a major client, boosting its mmWave wireless momentum. With Q2 2025 shipments underway and urban rollouts expanding in Los Angeles, CEO Ron Glibbery detailed the company's breakthroughs on The Street Reports Podcast listen now.

These multi-sector breakthroughs showcase disruptive innovation in healthcare, biotech, mining, wireless signals and global health—driving market momentum and investor interest.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.